Financial Year |
March 31 2023 |
Monetary Funds |
4,041,682,366.13 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
659,118,486.10 |
Advances to Suppliers |
11,437,931.00 |
Other Receivables |
17,215,817.76 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
1,299,079.31 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
1,707,934,575.38 |
Total Current Assets |
6,438,688,255.68 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
4,725,477.63 |
Investment Properties |
-- |
Fixed Assetes |
6,017,569,930.14 |
Under-construction Projects |
6,818,017,634.04 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
823,342,434.73 |
R&D expenses |
-- |
Goodwill |
384,646,883.39 |
Long-Term Deferred and Prepaid Expenses |
86,769.30 |
Deferred Income Tax Assets |
5,385,673.54 |
Other Non-Current Assets |
282,469,939.53 |
Sub-Total of Non-Current Assets |
14,504,743,445.78 |
Total Assets |
20,943,431,701.46 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
74,979,342.68 |
Accounts Payable |
1,016,619,712.94 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
12,707,025.93 |
Taxes Payable |
4,800,558.73 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
256,069,473.83 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,352,616,714.30 |
Other Current Liabilities |
-- |
Sub-Total of Current Liabilities |
2,717,792,828.41 |
Long-term Loans |
8,418,529,440.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
1,684,648,742.44 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
241,464,804.15 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
10,446,431,562.08 |
Total Liabilities |
13,164,224,390.49 |
Paid-In Capital(Or Share Stock) |
744,284,149.02 |
Capital Surplus |
5,625,142,071.14 |
Surplus Reserve |
192,780,905.74 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,188,767,509.95 |
Minority Stockholder's Interest |
28,232,675.12 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,750,974,635.85 |
Owner's Equity(Stockholder's Equity) |
7,779,207,310.97 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
20,943,431,701.46 |